Ross L Coppel Selected Research

2-octynoic acid

1/2013	Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis.
11/2011	Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity.
8/2008	Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease.
5/2005	Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ross L Coppel Research Topics

Disease

61	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 01/2002
55	Malaria 01/2021 - 02/2002
22	Infections 01/2022 - 12/2002
13	Cholangitis 02/2013 - 08/2007
9	Inflammation (Inflammations) 01/2019 - 11/2002
8	Tuberculosis (Tuberculoses) 05/2020 - 04/2007
8	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2019 - 09/2003
8	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 01/2002
6	Liver Diseases (Liver Disease) 05/2014 - 12/2002
4	Colitis 10/2012 - 03/2009
3	Sclerosing Cholangitis 11/2014 - 11/2002
3	Neoplasms (Cancer) 01/2013 - 08/2004
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2010 - 06/2008
2	Rheumatoid Arthritis 12/2009 - 12/2003
2	Starvation 09/2007 - 09/2005
2	Communicable Diseases (Infectious Diseases) 09/2006 - 10/2004
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Coinfection 12/2021
1	HIV Infections (HIV Infection) 01/2021
1	Hypoxia (Hypoxemia) 01/2015
1	Human Influenza (Influenza) 05/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2013
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2012
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2012

Drug/Important Bio-Agent (IBA)

35	AntibodiesIBA 01/2021 - 01/2003
30	Proteins (Proteins, Gene)FDA Link 11/2020 - 02/2002
25	AntigensIBA 12/2021 - 07/2002
20	VaccinesIBA 01/2021 - 08/2002
15	AutoantibodiesIBA 09/2013 - 01/2002
13	XenobioticsIBA 01/2017 - 11/2003
10	Immunoglobulin G (IgG)IBA 01/2022 - 01/2003
10	AutoantigensIBA 01/2017 - 01/2002
9	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 01/2022 - 05/2003
9	CytokinesIBA 05/2014 - 06/2006
8	EpitopesIBA 01/2019 - 01/2002
7	Immunoglobulin M (IgM)IBA 01/2017 - 01/2003
7	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 10/2012 - 08/2006
6	Merozoite Surface Protein 1 (MSA1)IBA 01/2019 - 12/2002
6	Membrane Proteins (Integral Membrane Proteins)IBA 02/2017 - 10/2004
6	EnzymesIBA 11/2014 - 07/2002
6	Oxidoreductases (Dehydrogenase)IBA 09/2013 - 12/2003
5	Interferon-gamma (Interferon, gamma)IBA 11/2020 - 06/2008
5	Subunit VaccinesIBA 04/2014 - 12/2002
5	LigandsIBA 10/2008 - 10/2005
4	RTS malaria vaccineIBA 01/2021 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 02/2017 - 07/2002
4	InterleukinsIBA 05/2014 - 11/2009
4	Pyruvic Acid (Pyruvate)IBA 09/2013 - 12/2003
4	2-octynoic acidIBA 01/2013 - 05/2005
3	Immunoglobulin A (IgA)IBA 01/2021 - 05/2004
3	Monoclonal AntibodiesIBA 01/2017 - 03/2009
3	Interleukin-17 (Interleukin 17)IBA 05/2014 - 02/2009
3	Interleukin-12 (IL 12)IBA 05/2014 - 10/2012
3	Malaria VaccinesIBA 04/2014 - 04/2012
3	Peptides (Polypeptides)IBA 09/2013 - 08/2003
3	Immunoglobulins (Immunoglobulin)IBA 02/2013 - 02/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009 - 06/2008
3	Surface Antigens (Surface Antigen)IBA 08/2008 - 07/2002
2	Freund's AdjuvantIBA 01/2019 - 05/2003
2	PolyethyleneimineIBA 02/2017 - 05/2013
2	Thioctic Acid (Lipoic Acid)IBA 01/2017 - 12/2003
2	Carrier Proteins (Binding Protein)IBA 07/2015 - 07/2014
2	Biomarkers (Surrogate Marker)IBA 07/2013 - 05/2009
2	Therapeutic UsesIBA 02/2013 - 07/2010
2	Interleukin-6 (Interleukin 6)IBA 07/2010 - 03/2009
2	ImmunosorbentsIBA 10/2009 - 10/2008
2	Recombinant ProteinsIBA 05/2009 - 12/2002
2	N 30IBA 03/2009 - 04/2006
2	Interleukin-2 Receptor alpha SubunitIBA 01/2009 - 11/2006
2	ProteomeIBA 12/2004 - 12/2004
2	CaspasesIBA 05/2004 - 01/2002
1	SuspensionsIBA 01/2022
1	Immunoglobulin E (IgE)IBA 12/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 11/2020
1	ProdrugsIBA 05/2020
1	TrehaloseIBA 01/2020
1	Polystyrenes (Polystyrene)IBA 01/2019
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2018
1	Interleukin-7 (Interleukin 7)IBA 01/2018
1	Cholic AcidIBA 01/2018
1	Hyaluronic Acid (Hyaluronan)IBA 02/2017
1	Hemagglutinins (Hemagglutinin)IBA 05/2014
1	Interleukin-12 Subunit p35IBA 05/2014
1	Interleukin-23 Subunit p19IBA 05/2014
1	Alanine (L-Alanine)FDA Link 09/2013
1	DNA VaccinesIBA 05/2013
1	LipidsIBA 04/2013
1	CTLA-4 AntigenIBA 02/2013
1	Abatacept (Orencia)FDA Link 02/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2013
1	CurcuminIBA 01/2013
1	TubulinIBA 01/2013
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2012
1	Interleukin-23 (Interleukin 23)IBA 10/2012
1	CD40 Ligand (CD40L)IBA 01/2012
1	Bovine Serum AlbuminIBA 11/2011

Therapy/Procedure

4	Therapeutics 05/2014 - 09/2003
2	Drug Therapy (Chemotherapy) 01/2012 - 04/2007
1	Mechanical Ventilators (Ventilator) 05/2014